Diffuse large B-cell lymphoma not otherwise specified ... "Survival Rates and Factors That Affect Prognosis (Outlook) for Non-Hodgkin Lymphoma," “Types of B-cell Lymphoma.” ...

A lymph node biopsy is the main method of diagnosing both non-Hodgkin’s and Hodgkin’s lymphoma, including diffuse large B-cell lymphoma, which is the most common form of non-Hodgkin’s lymphoma.

Liso-Cel is a type of CAR T-cell therapy — a revolutionary approach that uses a patient's own immune cells to fight cancer.

If you or a loved one has diffuse large B-cell lymphoma (DLBCL) that is no longer responding to treatment or came back after treatment, chimeric antigen receptor (CAR) T-cell therapy may be an option.

In this Q&A, Carly Stafford Dixon discusses her lymphoma journey, recovery with CAR T therapy, and mission to raise support ...

Researchers sought to assess the access to CAR-T therapy for patients within community-based and transplant cell therapy networks.

The CRISPR company is laying off about a third of its employees and stopping work on an experimental lupus treatment in a bid ...

Australian patients with the most common form of lymphoma will for the first time have access to affordable, at-home treatment options after the federal subsidisation of an injectable immunotherapy.

Dizal will also present results from the ongoing Phase I/II study of DZD6008, a 4th generation EGFR TKI with full BBB penetration, in advanced EGFR mutation positive (EGFRm) non-small cell lung cancer ...

Results showed significant improvement in safety as measured by treatment-related morbidity and non-inferior progression-free survival (PFS). The HD21 trial enrolled patients with advanced Hodgkin ...